Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
Status:
Completed
Trial end date:
2018-12-19
Target enrollment:
Participant gender:
Summary
This single center, randomized, single dose, full replicate, crossover comparative
laboratory-blinded study will be conducted in healthy male and female volunteers in order to
determine the bioequivalence of two different formulations of telmisartan 80 mg tablets after
oral administration under fasting conditions.